Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 11,427 | 1,174 | 7,269 | 1,744 | 1,766 |
| Gross Profit | 11,427 | 1,174 | 7,269 | 1,744 | 1,766 |
| Operating Expenses | 16,161 | 15,994 | 17,365 | 19,671 | 17,381 |
| Operating Income | -4,734 | -14,820 | -10,096 | -17,927 | -15,615 |
| Interest Expense | 495 | 485 | 487 | 490 | 425 |
| Other Income | 962 | 76 | -52 | -49 | 918 |
| Pre-tax Income | -4,267 | -15,229 | -10,635 | -18,466 | -15,122 |
| Net Income Continuous | -4,267 | -15,229 | -10,635 | -18,466 | -15,122 |
| Net Income | $-4,267 | $-15,229 | $-10,635 | $-18,466 | $-15,122 |
| EPS Basic Total Ops | -0.20 | -1.20 | -0.90 | -1.60 | -1.20 |
| EPS Basic Continuous Ops | -0.16 | -1.23 | -0.90 | -1.60 | -1.27 |
| EPS Diluted Total Ops | -0.20 | -1.20 | -0.90 | -1.60 | -1.20 |
| EPS Diluted Continuous Ops | -0.16 | -1.23 | -0.90 | -1.60 | -1.27 |
| EBITDA(a) | $-4,163 | $-14,237 | $-9,435 | $-16,968 | $-14,827 |